AI adoption trends projected to boost the growth of Embolization Market
Embolization Market |
Market Overview:
Embolization is a minimally invasive procedure used
for blocking blood vessels through the purposeful introduction of materials
such as micro coils, liquids, foams and particles into the blood vessel leading
to occlusion. This procedure is frequently used to treat cancerous growths,
uterine fibroids and abnormal blood vessel formations. It offers advantages
such as minimal scarring, reduced risks of infection and bleeding and shorter
recovery time. With advancements in minimally invasive procedures and growing
adoption of AI technology, the demand for embolization procedures is on the
rise.
Market key trends:
Rising demand for minimally invasive procedures: Advances in interventional
radiology and AI guidance systems have increased the adoption of minimally
invasive procedures over conventional open surgeries. Minimally invasive procedures
offer benefits such as reduced post-procedure pain, lower risk of infection and
scarring. Growing awareness about advantages of embolization procedures is
fueling their demand.
Increasing research and development: Key players are increasingly investing in
R&D to develop advanced embolization devices and fluids such as drug
eluting microspheres and detachable coils. Ongoing research to expand the
application scope of embolization procedures for treatment of other diseases
and conditions is also supporting market growth. Adoption of AI and robotics:
Integration of AI technology and robotics offers benefits such as improved
accuracy, minimal invasiveness and shorter procedure time. With increasing AI
adoption trends, companies are developing AI-guided embolization systems which
can expand the market potential over the forecast period.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate as
significant capital investment is required to build manufacturing facilities
and establish distribution channels. In addition, established players enjoy
economies of scale and brand loyalty that provides them an advantage over new
players.
Bargaining power of buyers: The bargaining power of buyers is moderate given
the availability of alternative treatment options for various diseases.
However, technological advancements are helping reduce healthcare costs.
Bargaining power of suppliers: The bargaining power of suppliers is low due to
the presence of many component suppliers and commodity-like nature of raw
materials.
Threat of new substitutes: The threat of new substitutes is low as embolization
techniques have significant advantages over alternative treatment options and
newer technologies usually enhance rather than replace existing techniques.
Competitive rivalry: Intense as major players compete based on product
portfolio expansion, pricing, and geographical presence.
Key Takeaways
The
Global Embolization Market Share is expected to witness high growth,
exhibiting CAGR of 8.1% over the
forecast period, due to increasing prevalence of cardiovascular, oncology and
neurological disorders. North America is the largest market for embolization
currently however Asia Pacific is poised to register fastest growth during the
forecast period driven by growing medical tourism, rising healthcare
investments and increasing incidence of target diseases.
Key players operating in the embolization market are IMBiotechnologies Ltd.,
ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation,
Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical
Systems, Inc., Cook Group, and Johnson & Johnson. Regional analysis related
content comprises Regional analysis related content
North America currently dominates the global embolization market owing to
advanced healthcare infrastructure, favorable reimbursement policies, new
product approvals and rising prevalence of chronic diseases in the region. Asia
Pacific region is expected to witness highest growth during the forecast period
owing to expanding medical tourism industry, rapidly increasing healthcare
spending and heavy burden of cancer and cardiovascular diseases.
Read
More:
https://www.dailyprbulletin.com/embolization-market-is-estimated-to-witness-high-growth/
Comments
Post a Comment